BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024

Stock Information for SIR Royalty Income Fund

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SIR Royalty Income Fund

BioSyent Releases Financial Results for First Quarter 2025
BioSyent Declares Second Quarter 2025 Dividend
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
BioSyent to Attend Planet MicroCap Showcase
BioSyent to Present at LD Micro New York Investor Conference
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year
BioSyent Announces Grant of Restricted Share Units

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.